To assess how seeding doses correlated with histological detection of tau, we immunostained mid-frontal cortex sections with an AD-specific conformational monoclonal (GT38) [19] or phospho-tau (AT8) antibody and used digital neuropathology assessments [5] to quantitate pathological tau burden (Fig. 3). Here, MAPT is linked to Alzheimer disease.